OneMedNet Corporation (ONMD) — Financial statements
Income statement, balance sheet, and cash flow for OneMedNet Corporation — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 1↑111.4% | 0.64↓37.0% | 1↓11.4% | 1↑5.6% | 1 | |
| Cost of Revenue | 2↑101.5% | 0.92↓19.7% | 1↓24.0% | 2↑25.5% | 1 | |
| Gross Profit | -0.50↓79.0% | -0.28↓117.8% | -0.13↑64.2% | -0.36↓217.4% | -0.11 | |
| Operating Expenses | ||||||
| R&D Expenses | 2↑3.3% | 1↓29.0% | 2↑29.8% | 2↑147.5% | 0.64 | |
| General & Administrative Expenses | 6↓9.3% | 7↑98.3% | 4↓72.5% | 13↑976.2% | 1 | |
| Selling & Marketing Expenses | 1↑53.3% | 0.83↓25.6% | 1↑16.4% | 0.96↑58.3% | 0.61 | |
| SG&A Expenses | 8↓2.6% | 8↑68.6% | 5↓66.3% | 14↑667.9% | 2 | |
| Other Expenses | 0.00 | 0.00 | 0.00↑100.0% | -8↓5395.1% | 0.15 | |
| Operating Expenses | 9↓1.7% | 9↑38.7% | 7↓8.6% | 7↑183.2% | 3 | |
| Total Costs & Expenses | 11↑7.6% | 10↑30.1% | 8↓11.2% | 9↑133.2% | 4 | |
| Operating Results | ||||||
| Operating Income | -10↓0.6% | -10↓40.2% | -7↑11.2% | -8↓184.6% | -3 | |
| Depreciation & Amortization | 0.07↑14.0% | 0.06↑103.6% | 0.03↑12.0% | 0.03↑72.8% | 0.01 | |
| EBITDA | -3↑73.1% | -10↑70.6% | -34↓10.9% | -30↓1013.5% | -3 | |
| EBIT | -3↑72.6% | -10↑70.4% | -34↓10.9% | -30↓1008.5% | -3 | |
| Interest & Other Income | ||||||
| Net Interest Income | -0.07↑54.4% | -0.15↓1236.4% | -0.01↑97.3% | -0.40↓106.4% | -0.20 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 0.07↓54.4% | 0.15↑1236.4% | 0.01↓97.3% | 0.40↑106.4% | 0.20 | |
| Non-Operating Income | -7↓1949.1% | 0.38↓98.6% | 27↑18.4% | 23↑64982.5% | 0.03 | |
| Other Income / Expenses | 7↑1415.5% | -0.52↑98.1% | -27↓18.4% | -23↓9765.4% | -0.23 | |
| Income Before Tax | -3↑72.4% | -10↑70.0% | -34↓10.9% | -30↓934.9% | -3 | |
| Income Tax Expense | 0.00↓50.0% | 0.00↓88.9% | 0.02↑5.9% | 0.02 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -3↑72.3% | -10↑70.0% | -34↓10.9% | -30↓935.4% | -3 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -3↑72.3% | -10↑70.0% | -34↓10.9% | -30↓935.4% | -3 | |
| Bottom-Line Net Income | -3↑72.3% | -10↑70.0% | -34↓10.9% | -30↓935.4% | -3 | |
| EPS (Basic) | -0.06↑83.3% | -0.36↑92.5% | -4.77↓90.0% | -2.51↓1155.0% | -0.20 | |
| EPS (Diluted) | -0.06↑83.3% | -0.36↑92.5% | -4.77↓90.0% | -2.51↓1155.0% | -0.20 | |
| Weighted Average Shares | 45↑58.7% | 28↑296.3% | 7↓41.6% | 12↓18.9% | 15 | |
| Weighted Average Diluted Shares | 45↑58.7% | 28↑296.3% | 7↓41.6% | 12↓18.9% | 15 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.